Results 111 to 120 of about 333,306 (159)
Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses. [PDF]
Cell RepCervantes Rincón T, Kapoor T, Keeffe JR, Simonelli L, Hoffmann HH, Agudelo M, Jurado A, Peace A, Lee YE, Gazumyan A, Guidetti F, Cantergiani J, Cena B, Bianchini F, Tamagnini E, Moro SG, Svoboda P, Costa F, Reis MG, Ko AI, Fallon BA, Avila-Rios S, Reyes-Téran G, Rice CM, Nussenzweig MC, Bjorkman PJ, Ruzek D, Varani L, MacDonald MR, Robbiani DF. +29 moreeuropepmc +1 more sourceCorrection: Colorectal anastomotic safety assessment using ICG fluorescence and flexible endoscopy (COLOSSEUM): a global survey of 1367 surgeons. [PDF]
Surg EndoscBelvedere A, Licardie E, Sochorova D, Boni L, Chand M, Perretta S, Wexner S, Arulampalam THA, Morales-Conde S, Hardon SF, COLOrectal Surgical Safety Enhanced Using Mixed Methods (COLOSSEUM) Collaborative group. +10 moreeuropepmc +1 more sourceReal-world challenges in hepatocellular carcinoma in Central America and the Caribbean: insights from a multinational expert survey. [PDF]
Front OncolPerelló C, Disla HJ, Coste P, Valdez M, Páez D, Rivera C, Loo Y, Mayorga T, Torres K, Pol E, Adames E, Mayo M, Morel LM, Gutierrez R, Calleja JL. +14 moreeuropepmc +1 more sourceReal-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study. [PDF]
Cancer Immunol ImmunotherKopp RM, Massari F, Grande E, Schieber TJ, Ürün Y, Kopecký J, Molina-Cerrillo J, Basso U, Kucharz J, Büttner T, Pichler R, Fiala O, Myint ZW, Galli L, Buchler T, Rizzo M, Bolek H, Bourlon MT, Conteduca V, Pinto A, Rizzo A, Rosellini M, Roviello G, Zgura A, Mollica V, Partl A, Yildirim A, Akova U, Buti S, Monteiro FSM, Soares A, Porta C, Bilen MA, Li H, Santoni M. +34 moreeuropepmc +1 more sourceDisease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network. [PDF]
J Neurol Neurosurg PsychiatryLorscheider J, Signori A, Subramaniam S, Benkert P, Vukusic S, Trojano M, Hillert J, Glaser A, Hyde R, Spelman T, Magyari M, Elberling F, Pontieri L, Koch-Henriksen N, Sørensen PS, Gerlach O, Prat A, Girard M, Eichau S, Grammond P, Horakova D, Ramo-Tello C, Roos I, Buzzard K, Lechner Scott J, Sánchez-Menoyo JL, Alroughani R, Prévost J, Kuhle J, Gray O, Mathey G, Michel L, Ciron J, De Sèze J, Maillart E, Ruet A, Labauge P, Zephir H, Kwiatkowski A, van der Walt A, Kalincik T, Butzkueven H, Italian MS Register, Observatoire Français de la Sclérose en Plaques (OFSEP), MSBase Study Group, Swedish MS Registry, Big MS Data Network. +46 moreeuropepmc +1 more sourcePembrolizumab plus Lenvatinib in patients with metastatic Renal Cell Carcinoma: real-world evidences from the international ARON- 1 study. [PDF]
Cancer Immunol ImmunotherPorta C, Massari F, Taha T, Grande E, Bourlon MT, Kanesvaran R, Basso U, Molina-Cerrillo J, Alonso-Gordoa T, Myint ZW, Fornarini G, Buttner T, Park SH, Ürün Y, De Giorgi U, Pichler R, Rescigno P, Buchler T, Studentova H, Melichar B, Ansari J, Mollica V, Kucharz J, Rizzo M, Rizzo A, Kopp RM, Buti S, Monteiro FSM, Soares A, Bamias A, Santoni M. +30 moreeuropepmc +1 more sourceRoCK and ROI: single-cell transcriptomics with multiplexed enrichment of selected transcripts and region-specific sequencing. [PDF]
Nat CommunMoro G, Mallona I, Barz MJ, Maillard J, Brügger MD, Fazilaty H, Szabo Q, Valenta T, Handler K, Kerlin F, Bastian L, Baldus CD, Moor AE, Zinzen R, Robinson MD, Brunner E, Basler K. +16 moreeuropepmc +1 more sourcePembrolizumab-axitinib versus nivolumab-cabozantinib as first-line therapy in patients with metastatic renal cell carcinoma: a retrospective real-world comparison (ARON-1). [PDF]
Cancer Immunol ImmunotherSantoni M, Roviello G, Grande E, De Giorgi U, Fiala O, Seront E, Molina-Cerrillo J, Pichler R, Myint ZW, Kucharz J, Kanesvaran R, Büttner T, Pichler M, Basso U, Kopecky J, Bourlon MT, Cerbone L, Buchler T, Pinto A, de Liaño AG, Gianni C, Zgura A, Rescigno P, Ansari J, Caffo O, Küronya Z, Vitale MG, Bhuva D, Catalano M, Vau N, Kopp RM, Buti S, Bamias A, Porta C, Sunela K, Massari F. +35 moreeuropepmc +1 more source